Vincent Alcazer

1.8k total citations · 1 hit paper
36 papers, 1.1k citations indexed

About

Vincent Alcazer is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Vincent Alcazer has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Vincent Alcazer's work include Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and CAR-T cell therapy research (5 papers). Vincent Alcazer is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and CAR-T cell therapy research (5 papers). Vincent Alcazer collaborates with scholars based in France, United States and Germany. Vincent Alcazer's co-authors include Stéphane Depil, Paola Bonaventura, Christophe Caux, Jenny Valladeau‐Guilemond, Sebastián Amigorena, Sandrine Valsesia‐Wittmann, Tala Shekarian, Laurie Tonon, Nicolas Chuvin and Alain Viari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Science Advances.

In The Last Decade

Vincent Alcazer

31 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cold Tumors: A Therapeutic Challenge for Immunotherapy

2019 797 citations Paola Bonaventura, Vincent Alcazer et al. Frontiers in Immunology profile →

Peers

Vincent Alcazer

ONCOL

IMMUN

PRM

Jenny Valladeau‐Guilemond France

Jill A. Gershan United States

Bianca von Scheidt Australia

Natalie B. Collins United States

Jessica Dal Col Italy

You Kawarada Japan

Michael Klichinsky United States

Briana G. Nixon United States

Ryan Demeter United States

Stéphanie Corgnac France

Jenny Valladeau‐Guilemond France

Vincent Alcazer

890 ×1.4

ONCOL

1.2k ×2.0

IMMUN

445 ×1.3

156 ×1.0

158 ×1.1

PRM

Citations per year, relative to Vincent Alcazer Vincent Alcazer (= 1×) peers Jenny Valladeau‐Guilemond

Countries citing papers authored by Vincent Alcazer

Since Specialization

Citations

This map shows the geographic impact of Vincent Alcazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Alcazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Alcazer more than expected).

Fields of papers citing papers by Vincent Alcazer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Alcazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Alcazer. The network helps show where Vincent Alcazer may publish in the future.

Co-authorship network of co-authors of Vincent Alcazer

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Alcazer. A scholar is included among the top collaborators of Vincent Alcazer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Alcazer. Vincent Alcazer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dubois, Valérie, Marie Balsat, Sophie Ducastelle, et al.. (2025). HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia. HemaSphere. 9(11). e70261–e70261.

Balsat, Marie, Hélène Labussière‐Wallet, Vincent Alcazer, et al.. (2025). Thrombocytosis drives alteration of primary hemostasis and acquired von willebrand syndrome occurrence in myeloproliferative neoplasms. Blood. 146(Supplement 1). 5570–5570.

Robe, Cyrielle, Nicolás Ortonne, Vincent Alcazer, et al.. (2025). Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model. Leukemia. 39(7). 1744–1755.

Mouton, William, Vincent Alcazer, Caroline Duprè, et al.. (2025). Temporal Evolution of Functional Immune Reconstitution after Allogeneic HSCT. Transplantation and Cellular Therapy. 31(6). 367–381.

Porteu, Françoise, et al.. (2024). Endogenous retroelements in hematological malignancies: From epigenetic dysregulation to therapeutic targeting. American Journal of Hematology. 100(1). 116–130. 3 indexed citations

Forcade, Édouard, Louis Terriou, Alice Garnier, et al.. (2024). Efficacy and Safety of Pegcetacoplan in PNH Patients with Extra-Vascular Hemolysis Under Anti-C5: The Real-Life Experience of the National French Reference Center. Blood. 144(Supplement 1). 1321–1321. 1 indexed citations

Bhatt, Aditi, Vincent Alcazer, Jean‐Marc Classe, et al.. (2023). Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer. Annals of Surgical Oncology. 30(6). 3287–3299. 3 indexed citations

Chabane, Kaddour, Carole Charlot, Thomas Simonet, et al.. (2023). Real life evaluation of AlphaMissense predictions in hematological malignancies. Leukemia. 38(2). 420–423. 10 indexed citations

Alcazer, Vincent, Paola Bonaventura, Laurie Tonon, et al.. (2022). HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. American Journal of Hematology. 97(9). 1200–1214. 15 indexed citations

10.

Alcazer, Vincent, et al.. (2022). Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy. European Journal of Cancer. 171. 96–105. 4 indexed citations

11.

Mouton, William, Anne Conrad, Vincent Alcazer, et al.. (2022). Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(2). 94.e1–94.e13. 5 indexed citations

12.

Bonaventura, Paola, Vincent Alcazer, Laurie Tonon, et al.. (2022). Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Science Advances. 8(4). eabj3671–eabj3671. 63 indexed citations

13.

Dubois, Valérie, Hélène Labussière‐Wallet, Fabienne Venet, et al.. (2022). Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Frontiers in Immunology. 13. 841470–841470. 15 indexed citations

14.

Alcazer, Vincent & Pierre Sujobert. (2022). Panel Informativity Optimizer. Journal of Molecular Diagnostics. 24(6). 697–709. 1 indexed citations

15.

Alcazer, Vincent & Stéphane Depil. (2021). Développement des CAR-T allogéniques. Bulletin du Cancer. 108(10). S73–S80. 2 indexed citations

16.

Conrad, Anne, Florent Valour, Vincent Alcazer, et al.. (2019). VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients. BMJ Open. 9(2). e026093–e026093. 8 indexed citations

17.

Alcazer, Vincent, Régis Peffault de Latour, Florence Ader, & Hélène Labussière‐Wallet. (2019). Non-prise de greffe allogénique de cellules souches hématopoïétiques : définition et facteurs de risque identifiés. Bulletin du Cancer. 106(6). 574–583. 2 indexed citations

18.

Alcazer, Vincent, Christophe Delenda, Laurent Poirot, & Stéphane Depil. (2018). Développement des CAR-T dans les tumeurs solides. Bulletin du Cancer. 105. S178–S187. 2 indexed citations

19.

Nicolini, Franck E., Vincent Alcazer, Pascale Cony‐Makhoul, et al.. (2018). Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on front-line imatinib. Experimental Hematology. 64. 97–105.e4. 6 indexed citations

20.

Alcazer, Vincent, Patrick Miailhes, Christophe Ramière, Caroline Charre, & Laurent Cotte. (2018). Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report. BMC Infectious Diseases. 18(1). 682–682. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact